英硅智能(03696)与罗欣药业(002793.SZ)达成 AI 制药战略合作,聚焦消化与代谢等慢性病创新药研发

智通财经
Nov 13

智通财经APP讯,英硅智能(03696)公布,公司的全资附属公司英硅智能科技(上海)有限公司近日与罗欣药业(002793.SZ)签署了战略合作协议。

根据战略合作协议,双方拟围绕创新药研发建立长期战略合作关系,推动人工智能技术与疾病领域专业知识、研究数据及研发经验的深度融合,共同探索具有临床价值和开发潜力的创新药研发。双方优先围绕消化系统疾病、代谢性疾病及其他非肿瘤慢性病领域探索合作,并根据实际进展,逐步拓展至双方共同认可的其他疾病领域。

双方按照“共同评估、分阶段实施、逐项目确认”的原则推进合作。依托各自资源优势、技术积淀与渠道能力,实现优势互补、协同发展,进一步提升公司核心竞争力,助力公司长远战略布局。具体合作方向包括:疾病研究与靶点发现、创新分子发现与优化、在研项目赋能、研发转化协同、技术与专业交流以及其他经双方同意的合作事项。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10